- Large-Scale Transfections.
- High-Growth Opportunities in Asian Market.
Target Audience for Study of Global Transfection Reagents and Equipment Market:
# Biopharmaceutical companies
# Biotechnology companies
# Transfection equipment, reagent, and kit manufacturing companies
# Suppliers and distributors of transfection reagents
# Research institutes
# Academic centers
# Venture capitalists
Global Industry Leaders:
The key players in this market are continuously striving to gain larger shares and expand their existing product portfolios by agreements, collaborations, and partnerships.
The overall market was dominated by Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands). Other players include Polyplus-transfection SA (France), Bio-Rad Laboratories Inc. (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte, Inc. (U.S.).
What the Market Looks Like?
The global transfection reagent market includes forecast from 2016 to 2021. This market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.
Download PDF Brochure @Download PDF Brochure
Global Geographical Scenario:
On the basis of region, the global transfection reagents and equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.
What Drives the Market?
The growth of the global Transfection Reagents and Equipment Industry is primarily influenced by the following factors:
# Technological Advancements in Transfection Technology
# Global Alliances Among Leading Research Institutes to Trigger Drug Discovery
# Increase in R&D Spending and Research Activities By Pharmaceutical and Biotech Companies
# Growing Research Activities in Cell Science
# Increase in Demand for Synthetic Genes
# Rising Incidence of Cancer Worldwide
Feel FREE to Connect to Our Research Experts for More Detailed Information@ Transfection Reagent Market
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.